Stefano Severi
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Publications by Year
Research Areas
Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research
Most-Cited Works
- → Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours(2013)143 cited
- → Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors(2015)141 cited
- → PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy(2018)129 cited
- → 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study(2014)122 cited
- → Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE(2016)118 cited
- → Treatment with the Radiolabelled Somatostatin Analog <sup>177</sup>Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors(2013)112 cited
- → PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest(2019)103 cited
- Dosimetry for treatment with radiolabelled somatostatin analogues. A review.(2010)
- → Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET(2015)100 cited
- → A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management(2016)100 cited